237 related articles for article (PubMed ID: 23702511)
1. Identification and characterisation of mutations associated with von Willebrand disease in a Turkish patient cohort.
Hampshire DJ; Abuzenadah AM; Cartwright A; Al-Shammari NS; Coyle RE; Eckert M; Al-Buhairan AM; Messenger SL; Budde U; Gürsel T; Ingerslev J; Peake IR; Goodeve AC
Thromb Haemost; 2013 Aug; 110(2):264-74. PubMed ID: 23702511
[TBL] [Abstract][Full Text] [Related]
2. Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients.
Yadegari H; Driesen J; Pavlova A; Biswas A; Hertfelder HJ; Oldenburg J
Thromb Haemost; 2012 Oct; 108(4):662-71. PubMed ID: 22871923
[TBL] [Abstract][Full Text] [Related]
3. The genetics of Canadian type 3 von Willebrand disease: further evidence for co-dominant inheritance of mutant alleles.
Bowman M; Tuttle A; Notley C; Brown C; Tinlin S; Deforest M; Leggo J; Blanchette VS; Lillicrap D; James P;
J Thromb Haemost; 2013 Mar; 11(3):512-20. PubMed ID: 23311757
[TBL] [Abstract][Full Text] [Related]
4. Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease.
Schneppenheim R; Budde U; Obser T; Brassard J; Mainusch K; Ruggeri ZM; Schneppenheim S; Schwaab R; Oldenburg J
Blood; 2001 Apr; 97(7):2059-66. PubMed ID: 11264172
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic and molecular characterisation of type 3 von Willebrand disease in a cohort of Indian patients.
Ahmad F; Budde U; Jan R; Oyen F; Kannan M; Saxena R; Schneppenheim R
Thromb Haemost; 2013 Apr; 109(4):652-60. PubMed ID: 23407766
[TBL] [Abstract][Full Text] [Related]
6. The genetic basis of von Willebrand disease.
Goodeve AC
Blood Rev; 2010 May; 24(3):123-34. PubMed ID: 20409624
[TBL] [Abstract][Full Text] [Related]
7. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
8. Aberrant dimerization of von Willebrand factor as the result of mutations in the carboxy-terminal region: identification of 3 mutations in members of 3 different families with type 2A (phenotype IID) von Willebrand disease.
Enayat MS; Guilliatt AM; Surdhar GK; Jenkins PV; Pasi KJ; Toh CH; Williams MD; Hill FG
Blood; 2001 Aug; 98(3):674-80. PubMed ID: 11468166
[TBL] [Abstract][Full Text] [Related]
9. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
10. Expression studies of missense mutations p.D141Y, p.C275S located in the propeptide of von Willebrand factor in patients with type 3 von Willebrand disease.
Baronciani L; Federici AB; Cozzi G; La Marca S; Punzo M; Rubini V; Canciani MT; Mannucci PM
Haemophilia; 2008 May; 14(3):549-55. PubMed ID: 18328061
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of mutations and molecular studies of type 2 von Willebrand disease.
Ahmad F; Jan R; Kannan M; Obser T; Hassan MI; Oyen F; Budde U; Saxena R; Schneppenheim R
Thromb Haemost; 2013 Jan; 109(1):39-46. PubMed ID: 23179108
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of the elusive mutation causing the historical von Willebrand Disease type IIC Miami.
Obser T; Ledford-Kraemer M; Oyen F; Brehm MA; Denis CV; Marschalek R; Montgomery RR; Sadler JE; Schneppenheim S; Budde U; Schneppenheim R
J Thromb Haemost; 2016 Sep; 14(9):1725-35. PubMed ID: 27344059
[TBL] [Abstract][Full Text] [Related]
13. Genetic heterogeneity in a large cohort of Indian type 3 von Willebrand disease patients.
Kasatkar P; Shetty S; Ghosh K
PLoS One; 2014; 9(3):e92575. PubMed ID: 24675615
[TBL] [Abstract][Full Text] [Related]
14. Laboratory and molecular characteristics of recessive von Willebrand disease type 2C (2A subtype IIC) of variable severity due to homozygous or double heterozygous mutations in the D1 and D2 domains.
Michiels JJ; Gadisseur A; van der Planken M; Schroyens W; Berneman Z
Acta Haematol; 2009; 121(2-3):111-8. PubMed ID: 19506357
[TBL] [Abstract][Full Text] [Related]
15. A new candidate mutation (N528S) within the von Willebrand factor propeptide identified in a Japanese patient with phenotype IIC of von Willebrand disease.
Gaucher C; Uno H; Yamazaki T; Mashiba H; Mazurier C
Eur J Haematol; 1998 Aug; 61(2):145-8. PubMed ID: 9714529
[TBL] [Abstract][Full Text] [Related]
16. Molecular Genetics of von Willebrand Disease in Korean Patients: Novel Variants and Limited Diagnostic Utility of Multiplex Ligation-Dependent Probe Amplification Analyses.
Kim HJ; Kim SK; Yoo KY; Lee KO; Yun JW; Kim SH; Kim HJ; Park SK
Ann Lab Med; 2019 Nov; 39(6):545-551. PubMed ID: 31240882
[TBL] [Abstract][Full Text] [Related]
17. Identification of two point mutations in the von Willebrand factor gene of three families with the 'Normandy' variant of von Willebrand disease.
Gaucher C; Mercier B; Jorieux S; Oufkir D; Mazurier C
Br J Haematol; 1991 Aug; 78(4):506-14. PubMed ID: 1832934
[TBL] [Abstract][Full Text] [Related]
18. Identification and functional analysis of a novel von Willebrand factor mutation in a family with type 2A von Willebrand disease.
Dong J; Zhao X; Shi S; Ma Z; Liu M; Wu Q; Ruan C; Dong N
PLoS One; 2012; 7(3):e33263. PubMed ID: 22479377
[TBL] [Abstract][Full Text] [Related]
19. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
[TBL] [Abstract][Full Text] [Related]
20. Expanded phenotype-genotype correlations in a pediatric population with type 1 von Willebrand disease.
Robertson JD; Yenson PR; Rand ML; Blanchette VS; Carcao MD; Notley C; Lillicrap D; James PD
J Thromb Haemost; 2011 Sep; 9(9):1752-60. PubMed ID: 21711445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
